May 17 (Reuters) - Endo International PLC ENDP.O :
* PHASE 3 DATA OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR THE INVESTIGATIONAL TREATMENT OF CELLULITE TO BE PRESENTED AT THE AESTHETIC MEETING 2019
* ENDO INTERNATIONAL - STATISTICALLY SIGNIFICANT IMPROVEMENTS WITH CCH VERSUS PLACEBO OBSERVED FOR 8 OF 8 (RELEASE-1) AND 7 OF 8 (RELEASE-2) SECONDARY ENDPOINTS